Lack of evidence for germline WWP1 pathogenic variants in gastrointestinal polyposis and other phenotypes suggestive of PTEN-hamartoma-tumor syndrome

• Noemi Gonzalez-Abuin,
• Tirso Pons,
• Teresa Fuster,
• Isabel Quintana,
• Mariona Terradas,
• Gemma Aiza,
• Joan Brunet,
• Gabriel Capellá,
• Heather Hampel,
• Laura Valle

Affiliations

Noemi Gonzalez-Abuin

Hereditary Cancer Program, Catalan Institute of Oncology, Oncobell Program, IDIBELL, Hospitalet de Llobregat, Barcelona 08908, Spain

Tirso Pons

Department of Immunology and Oncology, National Center for Biotechnology, Spanish National Research Council (CNB-CSIC), Madrid 28049, Spain

Teresa Fuster

Hereditary Cancer Program, Catalan Institute of Oncology, Oncobell Program, IDIBELL, Hospitalet de Llobregat, Barcelona 08908, Spain

Isabel Quintana

Hereditary Cancer Program, Catalan Institute of Oncology, Oncobell Program, IDIBELL, Hospitalet de Llobregat, Barcelona 08908, Spain

Mariona Terradas

Hereditary Cancer Program, Catalan Institute of Oncology, Oncobell Program, IDIBELL, Hospitalet de Llobregat, Barcelona 08908, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid 28029, Spain

Gemma Aiza

Hereditary Cancer Program, Catalan Institute of Oncology, Oncobell Program, IDIBELL, Hospitalet de Llobregat, Barcelona 08908, Spain

Joan Brunet

Hereditary Cancer Program, Catalan Institute of Oncology, Oncobell Program, IDIBELL, Hospitalet de Llobregat, Barcelona 08908, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid 28029, Spain; Catalan Institute of Oncology, IDIBGi, Girona 17007, Spain

Gabriel Capellá

Hereditary Cancer Program, Catalan Institute of Oncology, Oncobell Program, IDIBELL, Hospitalet de Llobregat, Barcelona 08908, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid 28029, Spain

Heather Hampel

Division of Clinical Cancer Genomics, Department of Medical Oncology & Therapeutic Research, City of Hope National Cancer Center, Duarte, CA 91010, USA

Laura Valle

Hereditary Cancer Program, Catalan Institute of Oncology, Oncobell Program, IDIBELL, Hospitalet de Llobregat, Barcelona 08908, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid 28029, Spain; Corresponding author. Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Av. Gran Via 199-203, Hospitalet de Llobregat, Barcelona 08908, Spain.